Advertisement
Heart, Lung and Circulation

Impact of Pre-Hospital Activation of STEMI on False Positive Activation Rate and Door to Balloon Time

Published:December 15, 2021DOI:https://doi.org/10.1016/j.hlc.2021.11.007

      Background

      Pre-hospital identification of ST-segment elevation myocardial infarction (STEMI) by paramedical staff reduces reperfusion time. However, the impact of this approach on the rate of unnecessary activation of coronary catheterisation lab (CCL) remains unclear.

      Methods

      The study reviewed consecutive STEMI patients over 3 years (July 2015 to June 2018) from all primary percutaneous coronary intervention (PPCI) centres and inter-hospital transfers (IHT) from non-PPCI capable centres in Western Australia. Out-of-hospital cardiac arrests (OOHCA) and STEMI calls for in-patients receiving treatment for other medical reasons were excluded.

      Results

      During the 3 years study period, 1,736 STEMI cases were recorded. Pre-hospital (PH) activation occurred in 799 (46%) cases. Median door to balloon time (D2BT) was 68 minutes (IQR 63 mins). D2BT for PH activation (40 min [IQR 25 min]) was significantly lower than both the PPCI centre emergency department (ED) activation (86 min [IQR 55 min]) and IHT activation groups (108 min [IQR 55 min]), p-value <0.00001. In PH activation group 98% patients received primary PCI in less than 90 minutes compared to 54% and 26% patients in the ED and the IHT activation groups, respectively.
      False positive STEMI activation rate was lower in the PH activation group (2.75%) compared to ED activation (5.4%) and IHT group (6%), p-value 0.0115. The false positive rate did not vary significantly between working hours and out-of-hour calls (5% vs 4%, p-value=0.304). Pericarditis, coronary artery disease other than STEMI, atypical chest pain, and stress induced cardiomyopathy were the common diagnoses in false positive activations.

      Conclusion

      Pre-hospital activation of STEMI leads to reduced door to balloon times without a significant increase in inappropriate procedures, though false positive activation rates are unclear. The majority of STEMI patients transferred from non-PPCI centres failed to receive reperfusion therapy within 90 minutes of initial hospital presentation. Further studies are required to assess the benefits of thrombolysis in selected patients in inter-hospital transfer group.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Antman E.M.
        • Anbe D.T.
        • Armstrong P.W.
        • Bates E.R.
        • Green L.A.
        • Hand M.
        • et al.
        ACC/AHA guidelines for the management of patients with ST elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).
        Circulation. 2004; 110: 82-292
        • Chew D.P.
        • Scott I.A.
        • Cullen L.
        • French J.K.
        • Briffa T.G.
        • Tideman P.A.
        • et al.
        • NHFA. CSANZ ACS Guideline 2016 Executive Working Group
        National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016.
        Heart Lung Circ. 2016; 25: 895
        • Lloyd-Jones D.
        • Adams R.J.
        • Brown T.M.
        • Carnethon M.
        • Dai S.
        • De Simone G.
        • Writing Group Members, et al
        Executive summary: heart disease and stroke statistics—2010 update: a report from the American Heart Association.
        Circulation. 2010; 121: 948-954
        • Cullen L.
        • Greenslade J.
        • Merollini K.
        • Graves N.
        • Hammett C.J.
        • Hawkins T.
        • et al.
        Cost and outcomes of assessing patients with chest pain in an Australian emergency department.
        Med J Aust. 2015; 202: 427-432
        • Roe M.T.
        • Parsons L.S.
        • Pollack C.V.
        • Canto J.G.
        • Barron H.V.
        • Every N.R.
        • et al.
        • National Registry of Myocardial Infarction Investigators
        Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non–ST-segment elevation myocardial infarction.
        Arch Intern Med. 2005; 165: 1630-1636
        • McNamara R.L.
        • Wang Y.
        • Herrin J.
        • Curtis J.P.
        • Bradley E.H.
        • Magid D.J.
        • et al.
        • NRMI Investigators
        Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction.
        J Am Coll Cardiol. 2006; 47: 2180-2186
        • Berger P.B.
        • Ellis S.G.
        • Holmes D.R.
        • Granger C.B.
        • Criger D.A.
        • Betriu A.
        • et al.
        Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.
        Circulation. 1999; 100: 14-20
        • De Luca G.
        • Suryapranata H.
        • Ottervanger J.P.
        • Antman E.M.
        Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts.
        Circulation. 2004; 109: 1223-1225
        • Rathore S.S.
        • Curtis J.P.
        • Chen J.
        • Wang Y.
        • Nallamothu B.K.
        • Epstein A.J.
        • et al.
        Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study.
        BMJ. 2009; 338: b1807
        • Kontos M.C.
        • Gunderson M.R.
        • Zegre-Hemsey J.K.
        • Lange D.C.
        • French W.J.
        • Henry T.D.
        • et al.
        Prehospital activation of hospital resources (PreAct) ST-segment–elevation myocardial infarction (STEMI): a standardized approach to prehospital activation and direct to the catheterization laboratory for STEMI recommendations from the American Heart Association's Mission: lifeline Program.
        J Am Heart Assoc. 2020; 9: e011963
        • Krumholz H.M.
        • Bradley E.H.
        • Nallamothu B.K.
        • Ting H.H.
        • Batchelor W.B.
        • Kline-Rogers E.
        • et al.
        A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality.
        JACC Cardiovasc Interv. 2008; 1: 97-104
        • Bradley E.H.
        • Herrin J.
        • Wang Y.
        • Barton B.A.
        • Webster T.R.
        • Mattera J.A.
        • et al.
        Strategies for reducing the door-to-balloon time in acute myocardial infarction.
        N Engl J Med. 2006; 355: 2308-2320
        • Curtis J.P.
        • Portnay E.L.
        • Wang Y.
        • McNamara R.L.
        • Herrin J.
        • Bradley E.H.
        • et al.
        The pre-hospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000-2002: findings from the National Registry of Myocardial Infarction-4.
        J Am Coll Cardiol. 2006; 47: 1544-1552
        • Sivagangabalan G.
        • Gerke A.M.
        • Narayan A.
        • Saddick N.
        • Thomas S.
        • Ross D.
        • et al.
        Western Sydney Emergency Triage of Acute Myocardial Infarction (ETAMI) experience-reduction in time to revascularisation, improvement in LVEF and 30 day Mortality.
        Circulation. 2006; 114 (ll420–1421)
        • Sivagangabalan G.
        • Ong A.
        • Gerke A.M.
        • Narayan A.
        • Sadick N.
        • Thomas S.P.
        • et al.
        Western Sydney Emergency Triage of Acute Myocardial Infarction (ETAMI) experience-effect of pre-hospital triage on 12 month mortality.
        Heart Lung Circ. 2007; 16: ll_527
        • Hutchison A.W.
        • Malaiapan Y.
        • Cameron J.D.
        • Meredith I.T.
        Pre-hospital 12 lead ECG to triage ST elevation myocardial infarction and long term improvements in door to balloon times: the first 1000 patients from the MonAMI project.
        Heart Lung Circ. 2013; 22: 910-916
        • Savage M.L.
        • Poon K.K.
        • Johnston E.M.
        • Raffel O.C.
        • Incani A.
        • Bryant J.
        • et al.
        Pre-hospital ambulance notification and initiation of treatment of ST elevation myocardial infarction is associated with significant reduction in door-to-balloon time for primary PCI.
        Heart Lung Circ. 2014; 23: 435-443
        • Pathak R.
        • Cox L.
        • Marley P.
        • Farshid A.
        Pre-hospital diagnosis of STEMI and impact on door to balloon time (TCH-AMI study).
        Heart Lung Circ. 2010; 19: S147
        • Nojoumian H.
        • Yu C.
        • McMahon R.
        • Hoo S.
        • Hansen P.
        • Rasmussen H.
        • et al.
        Does emergency triage of acute myocardial infarction (ETAMI) increase unnecessary coronary angiography? A 5-year comparison of field triage versus emergency department triage.
        Heart Lung Circ. 2009; 18: S208
        • Lange D.C.
        • Rokos I.C.
        • Garvey J.L.
        • Larson D.M.
        • Henry T.D.
        False activations for ST-segment elevation myocardial infarction.
        Interv Cardiol Clin. 2016; 5: 451-469
        • Baran K.L.
        • Lange D.
        • Ajoku A.
        • Kavian J.A.
        • Hildebrandt D.
        • Kontos M.C.
        • et al.
        Prospective assessment of the mission: lifeline PreAct-STEMI algorithm to reduce false activation of the cardiac catheterization laboratory.
        J Am Coll Cardiol. 2018; 71: A1171
        • Henry T.D.
        • Younger L.
        • Derakhshan A.
        • Conte S.
        • Pappas-Block E.
        • Makkar R.
        • et al.
        Economic impact of false ST-segment elevation myocardial infarction (STEMI) cardiac catheterization laboratory (CCL) activations at a major Los Angeles county STEMI-receiving center (SRC).
        J Am Coll Cardiol. 2016; 67: 635
        • Sawyer K.N.
        • Robinson A.L.
        • Roberts C.S.
        • Kurz M.C.
        • Kontos M.C.
        Pre-hospital and emergency department false-positive cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction: what is the “Cost of Doing Business”?.
        Circulation. 2012; 126: A17753
        • Tolles J.
        • Bosson N.
        • Kaji A.H.
        • Henry T.D.
        • French W.J.
        • Gausche-Hill M.
        • et al.
        The effect of implementation of the American Heart Association Mission Lifeline preact algorithm for prehospital cardiac catheterization laboratory activation on the rate of “false positive” activations.
        Prehosp Disaster Med. 2020; 35: 388-396
        • McCabe J.M.
        • Armstrong E.J.
        • Kulkarni A.
        • Hoffmayer K.S.
        • Bhave P.D.
        • Garg S.
        • et al.
        Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention–capable centers: a report from the Activate-SF registry.
        Arch Intern Med. 2012; 172: 864-871
        • Lange D.C.
        • Conte S.
        • Pappas-Block E.
        • Hildebrandt D.
        • Nakamura M.
        • Makkar R.
        • et al.
        Cancellation of the cardiac catheterization lab after activation for ST-segment–elevation myocardial infarction: frequency, etiology, and clinical outcomes.
        Circ Cardiovasc Qual Outcomes. 2018; 11: e004464
        • O’Gara P.T.
        • Kushner F.G.
        • Ascheim D.D.
        • Casey D.E.
        • Chung M.K.
        • de Lemos J.A.
        • et al.
        • American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
        2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        Circulation. 2013; 127: e362-e425
        • Ibanez B.
        • James S.
        • Agewall S.
        • Antunes M.J.
        • Bucciarelli-Ducci C.
        • Bueno H.
        • et al.
        2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
        Eur Heart J. 2018; 39: 119-177
        • Kontos M.C.
        • Kurz M.C.
        • Roberts C.S.
        • Joyner S.E.
        • Kreisa L.
        • Ornato J.P.
        • et al.
        An evaluation of the accuracy of emergency physician activation of the cardiac catheterization laboratory for patients with suspected ST-segment elevation myocardial infarction.
        Ann Emerg Med. 2010; 55: 423-430
        • Squire B.T.
        • Tamayo-Sarver J.H.
        • Rashi P.
        • Koenig W.
        • Niemann J.T.
        Effect of prehospital cardiac catheterization lab activation on door-to-balloon time, mortality, and false-positive activation.
        Prehosp Emerg Care. 2014; 18: 1-8
        • Jacobs A.K.
        • Antman E.M.
        • Ellrodt G.
        • Faxon D.P.
        • Gregory T.
        • Mensah G.A.
        • et al.
        American Heart Association’s Acute Myocardial Infarction (AMI) Advisory Working Group, recommendation to develop strategies to increase the number of ST-segment–elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention.
        Circulation. 2006; 113: 2152-2163
        • Nallamothu B.K.
        • Bates E.R.
        • Herrin J.
        • Wang Y.
        • Bradley E.H.
        • Krumholz H.M.
        Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis.
        Circulation. 2005; 111: 761-767
        • Bainey K.R.
        • Armstrong P.W.
        • Zheng Y.
        • Brass N.
        • Tyrrell B.D.
        • Leung R.
        • et al.
        Pharmacoinvasive strategy versus primary percutaneous coronary intervention in ST-elevation myocardial infarction in clinical practice: insights from the vital heart response registry.
        Circ Cardiovasc Interv. 2019; 12: e008059
        • Nallamothu B.K.
        • Antman E.M.
        • Bates E.R.
        Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?.
        Am J Cardiol. 2004; 94: 772-774
        • Garvey J.L.
        • Monk L.
        • Granger C.B.
        • Studnek J.R.
        • Roettig M.L.
        • Corbett C.C.
        • et al.
        Rates of cardiac catheterization cancelation for ST-segment elevation myocardial infarction after activation by emergency medical services or emergency physicians: results from the North Carolina Catheterization Laboratory Activation Registry.
        Circulation. 2012; 125: 308-313
        • Lu J.
        • Bagai A.
        • Buller C.
        • Cheema A.
        • Graham J.
        • Kutryk M.
        • et al.
        Incidence and characteristics of inappropriate and false-positive cardiac catheterization laboratory activations in a regional primary percutaneous coronary intervention program.
        Am Heart J. 2016; 173: 126-133
        • Mixon T.A.
        • Suhr E.
        • Caldwell G.
        • Greenberg R.D.
        • Colato F.
        • Blackwell J.
        • et al.
        Retrospective description and analysis of consecutive catheterization laboratory ST-segment elevation myocardial infarction activations with proposal, rationale, and use of a new classification scheme.
        Circ Cardiovasc Qual Outcomes. 2012; 5: 62-69
        • Regueiro A.
        • Fernández-Rodríguez D.
        • Freixa X.
        • Bosch X.
        • Martín-Yuste V.
        • Brugaletta S.
        • et al.
        False positive STEMI activations in a regional network: comprehensive analysis and clinical impact. Results from the Catalonian Codi Infart Network.
        Revista Española de Cardiología (English Edition). 2018; 71: 243-249
        • Larson D.M.
        • Menssen K.M.
        • Sharkey S.W.
        • Duval S.
        • Schwartz R.S.
        • Harris J.
        • et al.
        “False-positive” cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction.
        JAMA. 2007; 298: 2754-2760
        • Thygesen K.
        • Alpert J.S.
        • Jaffe A.S.
        • Chaitman B.R.
        • Bax J.J.
        • Morrow D.A.
        • et al.
        • Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction
        Fourth universal definition of myocardial infarction (2018).
        J Am Coll Cardiol. 2018; 72: 2231-2264
        • Boivin-Proulx L.A.
        • Matteau A.
        • Pacheco C.
        • Bastiany A.
        • Mansour S.
        • Kokis A.
        • et al.
        Effect of real-time physician oversight of prehospital STEMI diagnosis on ECG-inappropriate and false positive catheterization laboratory activation.
        CJC Open. 2021; 3: 419